Pharma giants AstraZeneca and Eli Lilly have scrapped two late-stage trials of an experimental Alzheimer’s drug they were co-developing, the latest blow in the long quest to find a breakthrough for the memory-robbing disorder.
from WSJ.com: US Business https://ift.tt/2HIa22F
via IFTTT
No comments:
Post a Comment